Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Hardcastle

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Radiation Therapy Target Objectives For Tonsillar Cancer Treated with Unilateral Radiation Therapy - A Replanning Study From TROG 12.01Glen Osbourne, Aimee Devlin, Nadia Walsh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2020
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for OligometastasesPaolo Sogono, Mathias Bressel, Steven David, et al.
Frontiers in Oncology|May 24, 2021
A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography ImagesKaushalya C Amarasinghe, Jamie Lopes, Julian Beraldo, et al.
Technology in Cancer Research & Treatment|January 11, 2015
Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy PlanningShankar Siva, Thomas Devereux, David L Ball, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 17, 2025
Exploring potential predictors of low muscle mass and muscle loss in adults with cancer: A scoping reviewAnnie R Curtis, Carla M Prado, Liliana Orellana, et al.
BMC Cancer|March 6, 2016
A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Shankar Siva, Tomas Kron, Mathias Bressel, et al.
Radiation Oncology (London, England)|February 14, 2024
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancerMuhammad Ali, Kendrick Koo, David Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 17, 2022
Practical considerations of single-fraction stereotactic ablative radiotherapy to the lungTherese Mj Kang, Nicholas Hardcastle, Anurag K Singh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2020
MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue doseJeremy Booth, Vincent Caillet, Adam Briggs, et al.
Radiation Oncology (London, England)|October 8, 2024
Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility studyNatalie Plant, Adam Mylonas, Chandrima Sengupta, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|January 11, 2026
Radiation Therapy Target Objectives For Tonsillar Cancer Treated with Unilateral Radiation Therapy - A Replanning Study From TROG 12.01Glen Osbourne, Aimee Devlin, Nadia Walsh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2020
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for OligometastasesPaolo Sogono, Mathias Bressel, Steven David, et al.
Frontiers in Oncology|May 24, 2021
A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography ImagesKaushalya C Amarasinghe, Jamie Lopes, Julian Beraldo, et al.
Technology in Cancer Research & Treatment|January 11, 2015
Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy PlanningShankar Siva, Thomas Devereux, David L Ball, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 17, 2025
Exploring potential predictors of low muscle mass and muscle loss in adults with cancer: A scoping reviewAnnie R Curtis, Carla M Prado, Liliana Orellana, et al.
BMC Cancer|March 6, 2016
A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Shankar Siva, Tomas Kron, Mathias Bressel, et al.
Radiation Oncology (London, England)|February 14, 2024
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancerMuhammad Ali, Kendrick Koo, David Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 17, 2022
Practical considerations of single-fraction stereotactic ablative radiotherapy to the lungTherese Mj Kang, Nicholas Hardcastle, Anurag K Singh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2020
MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue doseJeremy Booth, Vincent Caillet, Adam Briggs, et al.
Radiation Oncology (London, England)|October 8, 2024
Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility studyNatalie Plant, Adam Mylonas, Chandrima Sengupta, et al.
Pageof 18